Bioassay

Reading File

Asking for Preferences

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have all the material needed for a comprehensive pharmacology exam-focused bioassay guide. Here it is:

Bioassay - Pharmacology Exam Guide

1. Definition

A bioassay (biological assay) is the estimation of the potency (or concentration) of a substance by measuring its effect on a living system - an intact animal, isolated tissue, cell line, or microorganism - and comparing it against a standard preparation.

Bioassays are used when:

The substance cannot be chemically characterized (e.g., complex mixtures)
The chemical structure is known but activity must be confirmed
The substance requires calibration against a biological standard (e.g., insulin, heparin, oxytocin)

2. Types of Bioassay

A. Graded (Quantitative) Dose-Response Assay

The response varies continuously with dose (e.g., blood pressure change, muscle contraction)
A single organism/tissue gives graded responses at increasing doses
Described mathematically by: E = (Emax × C) / (C + EC50)
The curve is hyperbolic on a linear scale, and sigmoidal on a log scale
Key parameters: EC50 (concentration producing 50% of maximal effect), Emax (maximal efficacy)

Classic examples:

Guinea pig ileum contraction for histamine
Rabbit uterus (Magnus preparation) for oxytocin
Frog rectus abdominis for acetylcholine
Cat blood pressure for adrenaline
Isolated rat uterus (Schultz-Dale) for histamine/allergen testing

B. Quantal (All-or-None) Dose-Response Assay

The response is binary - either it occurs or it doesn't (e.g., convulsion, death, sleep, analgesia)
Each individual has a threshold dose - below it, no effect; above it, full effect
A population shows a normal (log-normal) distribution of threshold doses
When cumulated, this gives the characteristic S-shaped sigmoid curve

3. Key Parameters

Parameter	Definition
ED50	Dose producing the desired effect in 50% of subjects (quantal)
TD50	Dose producing toxicity in 50% of subjects
LD50	Dose causing death in 50% of subjects
EC50	Concentration producing 50% of maximal effect (graded)
Emax	Maximal possible effect of a drug
Potency	Dose/concentration needed for 50% effect; determined by EC50 or ED50
Efficacy	Maximum response a drug can produce (Emax); independent of potency

Exam tip: A drug can be MORE POTENT (lower ED50) but LESS EFFICACIOUS (lower Emax) than another. These are independent concepts.

4. Therapeutic Index (TI)

$$TI = \frac{LD_{50}}{ED_{50}}$$

A higher TI = safer drug (wide margin between effective and lethal doses)
Inhalational anesthetics have TI of only 2-4 - among the most dangerous drugs in clinical use (Miller's Anesthesia)

Therapeutic Window (clinically more useful):

The range between the minimum effective dose and the minimum toxic dose
Overlapping therapeutic and toxic dose ranges = narrow therapeutic window (e.g., digoxin, warfarin, lithium, aminoglycosides)

Certain safety factor (CSF) = LD1 / ED99

More conservative: the dose that kills 1% vs. dose effective in 99%
If LD1 < ED99, the drug is clinically unacceptable

Quantal Dose-Effect Curves showing ED50 and LD50 with frequency distributions and cumulative S-curves

Fig: Quantal dose-effect plot. Blue curve = cumulative therapeutic effect; Red curve = cumulative lethal effect. ED50 ~5 mg, LD50 ~160 mg, giving TI = 32 - Katzung's Basic & Clinical Pharmacology, 16th Ed.

5. Competitive vs. Non-competitive Antagonism in Bioassays

This is tested by constructing dose-response curves in the presence of increasing concentrations of antagonist:

Feature	Competitive Antagonist	Non-competitive (Irreversible) Antagonist
Effect on Emax	Unchanged (can be overcome)	Reduced (cannot be overcome)
Effect on EC50	Shifted RIGHT (increased)	May or may not change EC50
Dose-response curve	Parallel right shift	Flattened (depressed ceiling)
Example	Atropine vs. ACh	Phenoxybenzamine vs. norepinephrine

Schild Equation (for competitive antagonism):

$$\frac{C'}{C} = 1 + \frac{[I]}{K}$$

Where C' = agonist concentration needed in presence of antagonist [I], K = dissociation constant of antagonist.

Competitive vs non-competitive antagonism dose-response curves

Fig A (left): Competitive antagonist causes parallel right shift of the agonist curve - Emax is preserved. Fig B (right): Non-competitive antagonist reduces Emax without changing EC50. - Katzung's Basic & Clinical Pharmacology, 16th Ed.

6. Methods of Bioassay

Matching method

The unknown dose is matched with a known standard until equal responses are obtained.

Interpolation method

Responses to unknown are read off a standard dose-response curve.

Bracketing method

Unknown dose is bracketed between two known standard doses.

Statistical methods

3-point assay, 4-point assay (2+2 dose assay) - most common in pharmacology
Uses parallel line dose-response curves; potency ratio is estimated from the horizontal distance between curves

7. Types by System Used

System	Example Assay	Substance Estimated
In vivo	Rabbit uterus contraction	Oxytocin
In vivo	Rat blood pressure	Adrenaline/ACh
In vivo	Blood glucose in rabbit	Insulin
In vitro	Guinea pig ileum	Histamine, ACh
In vitro	Rat uterus (oestrogen-primed)	Oxytocin
In vitro	Frog heart	Digitalis glycosides
Cell-based	cAMP production in cells	LH, FSH (now replaced by immunoassay)

Note: According to Tietz Textbook of Laboratory Medicine, bioassays for hormones are largely replaced by immunoassays and mass spectrometry in modern clinical laboratories because bioassays are imprecise and labor-intensive.

8. Advantages and Disadvantages

Advantages	Disadvantages
Detects biologically active forms	Imprecise (high variability)
No need for chemical characterization	Time-consuming
Can detect synergism/antagonism	Requires animals or cell cultures
Measures total biological activity	Ethical concerns (animal use)
Useful for complex biological preparations	Cannot distinguish between related compounds

9. High-Yield Exam Points

Potency is about the dose needed (ED50); efficacy is about the maximum effect (Emax)
A partial agonist has intrinsic activity (α) between 0 and 1; it is an antagonist at high agonist concentrations
Competitive antagonism = parallel rightward shift of dose-response curve, Emax preserved
Non-competitive antagonism = Emax depressed, curve cannot be overcome
Therapeutic Index = LD50/ED50 (higher = safer)
Certain safety factor = LD1/ED99 (more conservative estimate of safety)
Guinea pig ileum contraction is the classic bioassay for histamine
Rabbit uterus (in vivo) or rat uterus (in vitro) is used for oxytocin
Blood glucose in fasted rabbits is the classic bioassay for insulin
Log dose-response curve is sigmoidal - this is the standard way to plot it for analysis

Sources: Katzung's Basic and Clinical Pharmacology, 16th Ed. | Miller's Anesthesia, 10th Ed. | Tietz Textbook of Laboratory Medicine, 7th Ed.

This is a shared conversation. Sign in to Orris to start your own chat.